AquaBounty seeks Canadian approval for biotech salmon

AquaBounty Technologies has taken the initial steps to seek approval in Canada for its biotech salmon as it awaits an FDA panel's review of the product. AquaBounty President and CEO Ronald Stotish said the Canadian application is in its early stages, but the company is "very interested because of our strong presence" in the country.

View Full Article in:

Gazette (Montreal) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA